These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16181396)

  • 1. External validation for fibrosis predicting index in hereditary hemochromatosis.
    Castiella A; Emparanza JI
    Am J Gastroenterol; 2005 Oct; 100(10):2366-7. PubMed ID: 16181396
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between iron accumulation and portal fibrosis.
    Senba M
    Isr J Med Sci; 1989 Nov; 25(11):650-1. PubMed ID: 2592182
    [No Abstract]   [Full Text] [Related]  

  • 3. Neonatal hemochromatosis: failure of deferoxamine therapy.
    Jonas MM; Kaweblum YA; Fojaco R
    J Pediatr Gastroenterol Nutr; 1987; 6(6):984-8. PubMed ID: 3681586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predicting liver fibrosis with non-invasive tests--a hope for the future].
    Marín Gabriel JC; Solís Herruzo JA
    Rev Esp Enferm Dig; 2008 Oct; 100(10):605-10. PubMed ID: 19119784
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary hemochromatosis: easily missed cause of cirrhosis, diabetes and heart failure.
    Giorgio AJ
    Geriatrics; 1973 Apr; 28(4):131-4. PubMed ID: 4700066
    [No Abstract]   [Full Text] [Related]  

  • 6. The CD8+ T-lymphocyte profile as a modifier of iron overload in HFE hemochromatosis: an update of clinical and immunological data from 70 C282Y homozygous subjects.
    Cruz E; Melo G; Lacerda R; Almeida S; Porto G
    Blood Cells Mol Dis; 2006; 37(1):33-9. PubMed ID: 16762569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
    Adams LA; Angulo P; Abraham SC; Torgerson H; Brandhagen D
    Liver Int; 2006 Apr; 26(3):298-304. PubMed ID: 16584391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver fibrosis in genetic hemochromatosis. Respective roles of iron and non-iron-related factors in 127 homozygous patients.
    Loréal O; Deugnier Y; Moirand R; Lauvin L; Guyader D; Jouanolle H; Turlin B; Lescoat G; Brissot P
    J Hepatol; 1992 Sep; 16(1-2):122-7. PubMed ID: 1484146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differential diagnosis of idiopathic hemochromatosis and liver cirrhosis with iron deposits].
    Kozuru M; Takeuchi K; Takahashi H; Masuya T
    Saishin Igaku; 1968 Oct; 23(10):2159-67. PubMed ID: 5716039
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatic cirrhosis].
    Popescu V; Arion C
    Rev Pediatr Obstet Ginecol Pediatr; 1980; 29(3):193-218. PubMed ID: 6781028
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of hemochromatosis.
    Spellberg MA
    Am J Gastroenterol; 1969 Jun; 51(6):516-22. PubMed ID: 4894612
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemochromatosis].
    Darnis F
    Nouv Presse Med; 1972 Jan; 1(3):159-62. PubMed ID: 5061525
    [No Abstract]   [Full Text] [Related]  

  • 13. Cirrhosis of the liver. A comparative study of the four major aetiological groups.
    Powell LW; Mortimer R; Harris OD
    Med J Aust; 1971 May; 1(18):941-50. PubMed ID: 5314134
    [No Abstract]   [Full Text] [Related]  

  • 14. Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort.
    Loko MA; Castera L; Dabis F; Le Bail B; Winnock M; Coureau G; Bioulac-Sage P; de Ledinghen V; Neau D;
    Am J Gastroenterol; 2008 Aug; 103(8):1973-80. PubMed ID: 18796094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis.
    Wood MJ; Powell LW; Ramm GA
    Blood; 2008 May; 111(9):4456-62. PubMed ID: 18316631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of silent liver fibrosis in hemochromatosis C282Y homozygotes with normal transaminase levels.
    Beaton M; Adams PC
    Clin Gastroenterol Hepatol; 2008 Jun; 6(6):713-4. PubMed ID: 18550006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCV and C282Y: a sinister synergism?
    Russo M; Grimm IS
    Gastroenterology; 1999 Feb; 116(2):494-5. PubMed ID: 9922334
    [No Abstract]   [Full Text] [Related]  

  • 18. Iron storage disorders in cirrhosis.
    Grace ND
    Conn Med; 1972 Oct; 36(10):559-63. PubMed ID: 5086114
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for hemochromatosis in asymptomatic subjects with or without a family history.
    Powell LW; Dixon JL; Ramm GA; Purdie DM; Lincoln DJ; Anderson GJ; Subramaniam VN; Hewett DG; Searle JW; Fletcher LM; Crawford DH; Rodgers H; Allen KJ; Cavanaugh JA; Bassett ML
    Arch Intern Med; 2006 Feb; 166(3):294-301. PubMed ID: 16476869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.